Moleculin Biotech, Inc. — Director's Dealing 2020

Jul 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2020-07-02

Reporting Person: PICKER DONALD H (Chief Science Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-02	Stock option (right to buy)	$0.928	A	100000	Acquired	2030-07-02	Common Stock (100000.0)	Direct

Footnotes

F1: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

F2: (2) Issued in connection with the reporting person's employment with the Company.